Cardiac Valve Disease: Clinical Trials

3 trials for Cardiac Valve Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Withdrawn 1
Phase 11Terminated 1

Follow Cardiac Valve Disease: new trials by email Literature Review of Cardiac Valve Disease trials Research Report on Cardiac Valve Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery
Hydroxocobalamin, Methylene Blue, Normal saline - Vasoplegia, Hypotension
Phase 2WithdrawnDartmouth-Hitchcock Medical Center2019-11-012020-03-02
The Val-CARD Trial
Sodium Valproate - Cardiac Valve Disease, Coronary Artery Disease
Phase 1 / Phase 2TerminatedUniversity of Leicester452018-11-062026-08-17
Passive Leg Raising Test to Predict Hypotension During Induction of Anesthesia in Patients Undergoing Cardiac Surgery
passive leg raising (45 degree leg elevation for 1-2 min) - Ischemic Heart Disease, Cardiac Valve Disease
Phase 2CompletedSeoul National University Hospital422009-08-012010-06-15

Narrower conditions

Heart Valve Diseases (3)  ·  Coronary Artery Disease (2)  ·  Hypotension (1)  ·  Multiple Organ Failure (1)  ·  Myocardial Ischemia (1)  ·  Vasoplegia (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Vascular Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Coronary Disease (2)  ·  Myocardial Ischemia (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Postoperative Complications (1)  ·  Shock (1)

Interventions

Hydroxocobalamin (1)  ·  Methylene Blue (1)  ·  Saline Solution (1)  ·  Valproic Acid (1)

Sponsors

Dartmouth-Hitchcock Medical Center (1)  ·  Seoul National University Hospital (1)  ·  University of Leicester (1)

Countries

South Korea (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Gavin Murphy, MD (1)  ·  Marius Roman, MD (1)  ·  Yunseok Jeon, M.D (1)

NIH funding

2018 (1)